Literature DB >> 1973257

Insulin and glucagon secretion in swimming mice: effects of autonomic receptor antagonism.

S Karlsson1, B Ahrén.   

Abstract

To study the regulation of islet hormone secretion in exercise-stress, we developed a swimming mouse model. Mice swam for 2, 6, or 10 minutes whereafter blood was sampled for analysis of plasma levels of insulin, glucagon, and glucose. Plasma insulin levels, which were not different from resting controls after 2 or 6 minutes of swimming, were slightly lower after 10 minutes of swimming (P less than .05). Plasma glucagon levels were increased after 2, 6, and 10 minutes of swimming (P less than .001), and plasma glucose levels were lower after 6 and 10 minutes of swimming (P less than .05). Glucose (5.6 mmol/kg)-stimulated insulin secretion was inhibited by 52% +/- 9% by the swimming (P less than .001). The mechanisms behind this inhibition of glucose-stimulated insulin secretion and the increase in basal plasma glucagon levels induced during 2 minutes of swimming were investigated by the use of autonomic receptor antagonists, administered intraperitoneally 20 minutes before the swimming period. The ganglionic antagonist hexamethonium (56 mumols/kg) prevented the swimming-induced inhibition of glucose-stimulated insulin secretion, indicating involvement of nerves in the inhibition. Also the nonselective alpha-adrenoceptor antagonist phentolamine (6.0 mumols/kg) and the alpha 2-adrenoceptor antagonist yohimbine (3.6 mumols/kg) prevented the inhibition of glucose-stimulated insulin secretion induced by swimming, whereas the beta-adrenoceptor antagonist L-propranolol (9.6 mumols/kg) had no effect. The swimming-induced increase in plasma glucagon levels was partially inhibited by hexamethonium by (58% +/- 24%, P less than .05). Phentolamine and yohimbine totally prevented the increase in plasma glucagon levels, whereas L-propranolol had no effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1973257     DOI: 10.1016/0026-0495(90)90108-o

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  7 in total

Review 1.  Galanin and the regulation of islet hormone secretion.

Authors:  B Ahrén; S Lindskog
Journal:  Int J Pancreatol       Date:  1992-06

2.  The role of LIM and SH3 protein-1 in bladder cancer metastasis.

Authors:  Misaki Sato; Mihoko Sutoh Yoneyama; Shingo Hatakeyama; Tomihisa Funyu; Tadashi Suzuki; Chikara Ohyama; Shigeru Tsuboi
Journal:  Oncol Lett       Date:  2017-08-23       Impact factor: 2.967

3.  Possible evidence for endogenous production of a novel galanin-like peptide.

Authors:  Z L Wang; R N Kulkarni; R M Wang; D M Smith; M A Ghatei; P G Byfield; W M Bennet; S R Bloom
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

4.  Intermittent hypoxia-induced glucose intolerance is abolished by α-adrenergic blockade or adrenal medullectomy.

Authors:  Jonathan C Jun; Mi-Kyung Shin; Ronald Devera; Qiaoling Yao; Omar Mesarwi; Shannon Bevans-Fonti; Vsevolod Y Polotsky
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-14       Impact factor: 4.310

Review 5.  Guidelines for animal exercise and training protocols for cardiovascular studies.

Authors:  David C Poole; Steven W Copp; Trenton D Colburn; Jesse C Craig; David L Allen; Michael Sturek; Donal S O'Leary; Irving H Zucker; Timothy I Musch
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-03-20       Impact factor: 4.733

6.  Energy homeostasis targets chromosomal reconfiguration of the human GH1 locus.

Authors:  Hana Vakili; Yan Jin; Peter A Cattini
Journal:  J Clin Invest       Date:  2014-10-08       Impact factor: 14.808

7.  Knock-in Luciferase Reporter Mice for In Vivo Monitoring of CREB Activity.

Authors:  Dmitry Akhmedov; Kavitha Rajendran; Maria G Mendoza-Rodriguez; Rebecca Berdeaux
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.